Leveraging TileDB to build a FAIR Data Platform at Takeda

Exploring the transformative solutions for managing multimodal data in the life sciences, a recent webinar highlighted the collaboration between TileDB and Zifo, which enables Takeda to accelerate drug discovery by building an R&D data platform that adheres to FAIR data principles. The life sciences are experiencing a data revolution due to omics technologies generating vast amounts of complex data, posing challenges in management, integration, and analysis, which require significant computational resources. TileDB addresses these challenges by offering a platform capable of storing and analyzing various data types, providing elastic distributed compute infrastructure, and ensuring robust data governance. This platform is instrumental at Takeda, allowing researchers to integrate clinical, genomic, and protein structure data, visualize patient-specific amino acid changes, and identify druggable protein regions, thereby potentially enhancing drug discovery processes. The innovative use of the platform is paving the way for future applications in single-cell and spatial transcriptomics data, emphasizing the necessity of managing multimodal data for advancing life sciences innovation and improving patient outcomes.